Advance Agrolife Fund Raise of ₹192.8 Cr

Advance Agrolife Board Meeting Date

Advance Agrolife's board meets on 4 November 2026 to approve unaudited standalone September quarter results. Trading window stays closed until 48 hours post-declaration.

Advance Agrolife Other Announcement

Advance Agrolife Ltd submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.

Advance Agrolife Price Movement Clarification

Advance Agrolife clarified that the volume spurt is purely market-driven. The company confirmed no undisclosed material information exists.

Advance Agrolife Legal & Regulatory

Advance Agrolife Limited received a GST Show Cause-cum-Demand Notice for FY 2022-23. The total proposed demand, including interest and penalty, is approximately ₹3.23 Crore.

Value

₹3.23 Cr

Advance Agrolife Management Change

Advance Agrolife Limited appointed Brijmohan Sharma as an Independent Director. Additionally, the company announced a designation change for Executive Director Narendra Choudhary.

Advance Agrolife Annual General Meeting

Advance Agrolife Limited filed the proceedings of its 24th Annual General Meeting held on September 18, 2026. Shareholders approved various business resolutions and director appointments.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.